Release Date: 28/08/09 08:56 Summary: Letter to Optionholders re Rights Issue Price Sensitive: No Download Document 43.47KB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market